Windlas Biotech Limited (BOM:543329)
India
· Delayed Price · Currency is INR 915.65
-2.80 (-0.30%)
At close: Jun 6, 2025
Windlas Biotech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 5, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
| Market Capitalization | 19,115 | 21,747 | 10,614 | 4,715 | 4,578 | - | Upgrade
|
| Market Cap Growth | 104.90% | 104.90% | 125.11% | 2.99% | - | - | Upgrade
|
| Enterprise Value | 17,048 | 19,806 | 8,990 | 2,946 | 2,605 | - | Upgrade
|
| Last Close Price | 915.65 | 1041.20 | 509.20 | 221.51 | 203.63 | - | Upgrade
|
| PE Ratio | 31.34 | 35.65 | 18.24 | 11.06 | 12.02 | - | Upgrade
|
| PS Ratio | 2.52 | 2.86 | 1.68 | 0.92 | 0.98 | - | Upgrade
|
| PB Ratio | 3.78 | 4.30 | 2.36 | 1.17 | 1.16 | - | Upgrade
|
| P/TBV Ratio | 3.83 | 4.36 | 2.38 | 1.18 | 1.16 | - | Upgrade
|
| P/FCF Ratio | 119.52 | 135.98 | 14.89 | - | - | - | Upgrade
|
| P/OCF Ratio | 28.03 | 31.89 | 9.74 | 7.73 | 50.14 | - | Upgrade
|
| EV/Sales Ratio | 2.24 | 2.61 | 1.43 | 0.57 | 0.56 | - | Upgrade
|
| EV/EBITDA Ratio | 18.12 | 21.05 | 11.80 | 5.02 | 5.05 | - | Upgrade
|
| EV/EBIT Ratio | 25.78 | 29.95 | 13.89 | 6.15 | 6.47 | - | Upgrade
|
| EV/FCF Ratio | 106.60 | 123.84 | 12.61 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | 0.01 | 0.01 | 0.02 | 0.16 | Upgrade
|
| Debt / EBITDA Ratio | 0.35 | 0.35 | 0.05 | 0.08 | 0.13 | 0.58 | Upgrade
|
| Debt / FCF Ratio | 2.04 | 2.04 | 0.05 | - | - | 5.77 | Upgrade
|
| Asset Turnover | 1.10 | 1.10 | 1.09 | 1.01 | 1.18 | 1.35 | Upgrade
|
| Inventory Turnover | 6.57 | 6.57 | 5.85 | 4.94 | 6.15 | 6.15 | Upgrade
|
| Quick Ratio | 1.63 | 1.63 | 1.99 | 2.06 | 3.08 | 1.43 | Upgrade
|
| Current Ratio | 2.11 | 2.11 | 2.51 | 2.92 | 4.06 | 2.08 | Upgrade
|
| Return on Equity (ROE) | 12.76% | 12.76% | 13.66% | 10.70% | 12.83% | 7.62% | Upgrade
|
| Return on Assets (ROA) | 5.96% | 5.96% | 7.00% | 5.87% | 6.40% | 8.55% | Upgrade
|
| Return on Capital (ROIC) | 8.33% | 8.33% | 9.40% | 7.40% | 7.95% | 11.54% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.90% | 12.90% | 14.20% | 11.70% | 10.10% | 21.40% | Upgrade
|
| Earnings Yield | 3.19% | 2.80% | 5.48% | 9.04% | 8.32% | - | Upgrade
|
| FCF Yield | 0.84% | 0.73% | 6.72% | -2.10% | -1.24% | - | Upgrade
|
| Dividend Yield | 0.60% | 0.56% | 1.08% | 1.81% | 1.72% | - | Upgrade
|
| Payout Ratio | 18.85% | 18.85% | 14.27% | 17.89% | - | - | Upgrade
|
| Buyback Yield / Dilution | -1.22% | -1.22% | 3.53% | -5.56% | -12.58% | - | Upgrade
|
| Total Shareholder Return | -0.62% | -0.66% | 4.61% | -3.75% | -10.86% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.